not approved
Sustainable High Molecular Weight Inhibitors (Phaseolamins) for regulation of glycemia in diabetes and metabolic syndrome, powered by Catalyst and Cardano.
Current Project Status
Unfunded
Amount
Received
Received
₳0
Amount
Requested
Requested
₳400,000
Percentage
Received
Received
0.00%
Solution
We will produce High Molecular Weight Inhibitors that have been proven effective for regulating glycemia. We will produce such a product from Chilean native sustainable sources (Phaseolus Vulgaris).
Problem
Diabetes and metabolic syndrome are common diseases, together affecting more than 1,5 BILLION people worldwide (IDF, 2022) and drastically affecting their quality of life and well-being.
Feasibility
Value for money
Impact / Alignment
Team
Team Connections